Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-28 @ 8:27 PM
Study NCT ID:
NCT00050102
Status:
COMPLETED
Last Update Posted:
2011-01-28
First Post:
2002-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: